Quick Summary
Brand: ZAKKOR
Form: Film-Coated Tablet
Type: Schedule H Drug
Ventito Pvt. Ltd. | Bengaluru
Diabetes Care
ZAKKOR
Vildagliptin 50mg + Metformin 500/1000mg
Achieve stable glycemic control with a dual-mechanism approach that targets both fasting and post-meal glucose levels.
First-line Choice
Metformin reduces glucose production in the liver.
DPP-4 Inhibitor
Vildagliptin enhances insulin release naturally.
Lipid Benefit
Proven to reduce LDL and triglyceride levels.
Clinical Indication
Indicated for adult patients with Type 2 Diabetes Mellitus when Metformin monotherapy is insufficient. It helps prevent long-term complications such as neuropathy, retinopathy, and kidney damage.
Dosage & Administration
Standard Dose: One tablet twice a day (Morning & Evening) after meals.
Naive Patients: Start with once daily after a meal; adjust to twice daily based on clinical response.
Safety & Contraindications
- Contraindicated in patients with Severe Renal Impairment (GFR < 30 ml/min).
- Not for patients with congestive heart failure or metabolic acidosis.
- Side Effects: GI issues like nausea are minimized when taken with food.
